speb/financial-data huggingface dataset:
ALAB income_statement (annual, 2024-12-31) — Cost Of Revenue: 93591000.00
ALAB balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 5418000.00
ALAB balance_sheet (annual, 2024-12-31) — Current Assets: 1012979000.00
ALAB balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1286000.00
ALAB balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 1286000.00
ALAB balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1286000.00
ALAB balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 1286000.00
ALAB balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 15000000.00
ALAB balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 15000000.00
ALAB balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 15000000.00
ALAB balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 15000000.00
ALAB balance_sheet (annual, 2024-12-31) — Current Liabilities: 86542000.00
ALAB cash_flow (annual, 2024-12-31) — Depreciation: 3154000.00
ALAB cash_flow (quarterly, 2024-12-31) — Depreciation: 974000.00
ALAB cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 3154000.00
ALAB cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3154000.00
ALAB income_statement (annual, 2024-12-31) — Diluted Average Shares: 131262000.00
ALAB income_statement (annual, 2024-12-31) — Diluted EPS: -0.64
ALAB income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -83421000.00
ALAB income_statement (annual, 2024-12-31) — EBIT: -116066000.00
ALAB income_statement (annual, 2024-12-31) — EBITDA: -112912000.00
ALAB cash_flow (annual, 2024-12-31) — End Cash Position: 80044000.00
ALAB cash_flow (annual, 2024-12-31) — Financing Cash Flow: 655838000.00
ALAB balance_sheet (annual, 2024-12-31) — Finished Goods: 16291000.00
ALAB cash_flow (annual, 2024-12-31) — Free Cash Flow: 102431000.00
ALAB cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1395000.00
ALAB balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 426000.00
ALAB income_statement (annual, 2024-12-31) — General And Administrative Expense: 94283000.00
ALAB balance_sheet (annual, 2024-12-31) — Gross PPE: 41484000.00
ALAB income_statement (annual, 2024-12-31) — Gross Profit: 302699000.00
ALAB cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 7793000.00
ALAB income_statement (annual, 2024-12-31) — Interest Income: 34288000.00
ALAB income_statement (annual, 2024-12-31) — Interest Income Non Operating: 34288000.00
ALAB balance_sheet (annual, 2024-12-31) — Inventory: 43215000.00
ALAB balance_sheet (annual, 2024-12-31) — Invested Capital: 964799000.00
ALAB cash_flow (annual, 2024-12-31) — Investing Cash Flow: -757568000.00
ALAB cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 672198000.00
ALAB cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
ALAB balance_sheet (annual, 2024-12-31) — Leases: 1159000.00
ALAB balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 353000.00
ALAB balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 353000.00
ALAB cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
ALAB cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 671132000.00
ALAB cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -1066000.00
ALAB income_statement (annual, 2024-12-31) — Net Income: -83421000.00
ALAB income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -83421000.00
ALAB income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -83421000.00
ALAB income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -83421000.00
ALAB income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -83421000.00
ALAB cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -83421000.00
ALAB income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -83421000.00
ALAB income_statement (annual, 2024-12-31) — Net Interest Income: 34288000.00
ALAB cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -721910000.00
ALAB income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 34288000.00
ALAB cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -24912000.00
ALAB cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
ALAB cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -1413000.00
ALAB balance_sheet (annual, 2024-12-31) — Net PPE: 35651000.00
ALAB cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -34245000.00
ALAB cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
ALAB balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 964799000.00
ALAB income_statement (annual, 2024-12-31) — Normalized EBITDA: -112912000.00
ALAB income_statement (annual, 2024-12-31) — Normalized Income: -83421000.00
ALAB cash_flow (annual, 2024-12-31) — Operating Cash Flow: 136676000.00
ALAB cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1395000.00
ALAB income_statement (annual, 2024-12-31) — Operating Income: -116066000.00
ALAB income_statement (annual, 2024-12-31) — Operating Revenue: 396290000.00
ALAB balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 162018000.00
ALAB balance_sheet (annual, 2024-12-31) — Other Current Assets: 16652000.00
ALAB balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 8404000.00
ALAB balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 426000.00
ALAB income_statement (annual, 2024-12-31) — Other Gand A: 94283000.00
ALAB cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2691000.00
ALAB balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5878000.00
ALAB balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 3167000.00
ALAB balance_sheet (annual, 2024-12-31) — Other Properties: 11261000.00
ALAB balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 834750000.00
ALAB balance_sheet (annual, 2024-12-31) — Payables: 26918000.00
ALAB balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 32336000.00
ALAB balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 29516000.00
ALAB balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
ALAB balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
ALAB cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
ALAB income_statement (annual, 2024-12-31) — Pretax Income: -81778000.00
ALAB cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 9618000.00
ALAB balance_sheet (annual, 2024-12-31) — Properties: 0.00
ALAB cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
ALAB cash_flow (annual, 2024-12-31) — Purchase Of Investment: -930575000.00
ALAB cash_flow (annual, 2024-12-31) — Purchase Of PPE: -34245000.00
ALAB balance_sheet (annual, 2024-12-31) — Raw Materials: 229000.00
ALAB balance_sheet (annual, 2024-12-31) — Receivables: 38811000.00
ALAB income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 93591000.00
ALAB income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3154000.00
ALAB cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1066000.00
ALAB income_statement (annual, 2024-12-31) — Research And Development: 200830000.00
ALAB balance_sheet (annual, 2024-12-31) — Retained Earnings: -208796000.00
ALAB cash_flow (annual, 2024-12-31) — Sale Of Investment: 208665000.00
ALAB income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 123652000.00
ALAB income_statement (annual, 2024-12-31) — Selling General And Administration: 217935000.00
ALAB balance_sheet (annual, 2024-12-31) — Share Issued: 162018000.00
ALAB cash_flow (annual, 2024-12-31) — Stock Based Compensation: 234588000.00
ALAB balance_sheet (annual, 2024-12-31) — Stockholders Equity: 964799000.00
ALAB balance_sheet (annual, 2024-12-31) — Tangible Book Value: 964799000.00
ALAB income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ALAB income_statement (annual, 2024-12-31) — Tax Provision: 1643000.00
ALAB income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
ALAB balance_sheet (annual, 2024-12-31) — Total Assets: 1054508000.00
ALAB balance_sheet (annual, 2024-12-31) — Total Capitalization: 964799000.00
ALAB balance_sheet (annual, 2024-12-31) — Total Debt: 1286000.00
ALAB balance_sheet (quarterly, 2024-12-31) — Total Debt: 1286000.00
ALAB balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 964799000.00
ALAB income_statement (annual, 2024-12-31) — Total Expenses: 512356000.00
ALAB balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 89709000.00
ALAB balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 41529000.00
ALAB balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3167000.00
ALAB income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -116066000.00
ALAB balance_sheet (annual, 2024-12-31) — Work In Process: 26695000.00
ALAB balance_sheet (annual, 2024-12-31) — Working Capital: 926437000.00
ALAB income_statement (quarterly, 2025-03-31) — +Operating Expense: 108126000.00
ALAB income_statement (quarterly, 2025-03-31) — +Total Revenue: 159442000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 29513000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 69778000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6958000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1216495000.00
ALAB cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -2542000.00
ALAB income_statement (quarterly, 2025-03-31) — Basic Average Shares: 163194000.00
ALAB income_statement (quarterly, 2025-03-31) — Basic EPS: 0.19
ALAB cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 80044000.00
ALAB cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4539000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Capital Stock: 16000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 86431000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 924726000.00
ALAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 386000.00
ALAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3940000.00
ALAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 10504000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2226000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -12365000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Inventory: -6787000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -689000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Payable: 2226000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -10139000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -14495000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Receivables: -30968000.00
ALAB cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -62389000.00
ALAB cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -30968000.00
ALAB cash_flow (quarterly, 2025-03-31) — Changes In Cash: 6950000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Common Stock: 16000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1041562000.00
ALAB cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
ALAB balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 29532000.00
ALAB income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 40031000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 8590000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Current Assets: 1075819000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 15000000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 15000000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 77280000.00
ALAB cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1125000.00
ALAB cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1125000.00
ALAB income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 178116000.00
ALAB income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.18
ALAB income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 31819000.00
ALAB income_statement (quarterly, 2025-03-31) — EBIT: 11285000.00
ALAB income_statement (quarterly, 2025-03-31) — EBITDA: 12410000.00
ALAB cash_flow (quarterly, 2025-03-31) — End Cash Position: 86994000.00
ALAB cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 386000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Finished Goods: 22654000.00
ALAB cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 5965000.00
ALAB cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 374000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2028000.00
ALAB income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 21870000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Gross PPE: 46432000.00
ALAB income_statement (quarterly, 2025-03-31) — Gross Profit: 119411000.00
ALAB income_statement (quarterly, 2025-03-31) — Interest Income: 10432000.00
ALAB income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 10432000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Inventory: 51057000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1041562000.00
ALAB cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3940000.00
ALAB cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
ALAB balance_sheet (quarterly, 2025-03-31) — Leases: 1947000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 407000.00
ALAB cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
ALAB cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
ALAB income_statement (quarterly, 2025-03-31) — Net Income: 31819000.00
ALAB income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 31819000.00
ALAB income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 31819000.00
ALAB income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 31819000.00
ALAB income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 31819000.00
ALAB cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 31819000.00
ALAB income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 31819000.00
ALAB income_statement (quarterly, 2025-03-31) — Net Interest Income: 10432000.00
ALAB cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 599000.00
ALAB income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 10432000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Net PPE: 39474000.00
ALAB cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -4539000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1041562000.00
ALAB income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 12410000.00
ALAB income_statement (quarterly, 2025-03-31) — Normalized Income: 31819000.00
ALAB cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 10504000.00
ALAB cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 374000.00
ALAB income_statement (quarterly, 2025-03-31) — Operating Income: 11285000.00
ALAB income_statement (quarterly, 2025-03-31) — Operating Revenue: 159442000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 164907000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 30258000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 10232000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2028000.00
ALAB income_statement (quarterly, 2025-03-31) — Other Gand A: 21870000.00
ALAB cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -329000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6401000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 2852000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Other Properties: 14546000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 838295000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Payables: 29513000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 38103000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 13945000.00
ALAB income_statement (quarterly, 2025-03-31) — Pretax Income: 21717000.00
ALAB cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 386000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ALAB cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
ALAB cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -190821000.00
ALAB cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -4539000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Raw Materials: 199000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Receivables: 69778000.00
ALAB income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 40031000.00
ALAB income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1125000.00
ALAB income_statement (quarterly, 2025-03-31) — Research And Development: 64554000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -176977000.00
ALAB cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 191420000.00
ALAB income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 21702000.00
ALAB income_statement (quarterly, 2025-03-31) — Selling General And Administration: 43572000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Share Issued: 164907000.00
ALAB cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 42446000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1041562000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1041562000.00
ALAB income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ALAB income_statement (quarterly, 2025-03-31) — Tax Provision: -10102000.00
ALAB income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
ALAB balance_sheet (quarterly, 2025-03-31) — Total Assets: 1121694000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1041562000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1041562000.00
ALAB income_statement (quarterly, 2025-03-31) — Total Expenses: 148157000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 80132000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 45875000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2852000.00
ALAB income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 11285000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Work In Process: 28204000.00
ALAB balance_sheet (quarterly, 2025-03-31) — Working Capital: 998539000.00
ALAB income_statement (quarterly, 2025-06-30) — +Operating Expense: 105789000.00
ALAB income_statement (quarterly, 2025-06-30) — +Total Revenue: 191925000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 31573000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 24318000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -7409000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1258581000.00
ALAB cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -1947000.00
ALAB income_statement (quarterly, 2025-06-30) — Basic Average Shares: 165428000.00
ALAB income_statement (quarterly, 2025-06-30) — Basic EPS: 0.31
ALAB cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 86994000.00
ALAB cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2023000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Capital Stock: 17000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 162328000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1065086000.00
ALAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 4737000.00
ALAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -63693000.00
ALAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 135366000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 2381000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 10773000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Inventory: -7790000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1274000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Payable: 2381000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 13154000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -3979000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Receivables: 45459000.00
ALAB cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 44881000.00
ALAB cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 45459000.00
ALAB cash_flow (quarterly, 2025-06-30) — Changes In Cash: 76410000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Common Stock: 17000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1135714000.00
ALAB cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
ALAB balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 43032000.00
ALAB income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 46362000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 21499000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Current Assets: 1180748000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 10000000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 10000000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 106383000.00
ALAB cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1392000.00
ALAB cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1392000.00
ALAB income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 178100000.00
ALAB income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.29
ALAB income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 51219000.00
ALAB income_statement (quarterly, 2025-06-30) — EBIT: 39774000.00
ALAB income_statement (quarterly, 2025-06-30) — EBITDA: 41166000.00
ALAB cash_flow (quarterly, 2025-06-30) — End Cash Position: 163404000.00
ALAB cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 4737000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Finished Goods: 34326000.00
ALAB cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 133343000.00
ALAB cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 1762000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2874000.00
ALAB income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 20456000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Gross PPE: 69484000.00
ALAB income_statement (quarterly, 2025-06-30) — Gross Profit: 145563000.00
ALAB income_statement (quarterly, 2025-06-30) — Interest Income: 10885000.00
ALAB income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 10885000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Inventory: 58602000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1135714000.00
ALAB cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -63693000.00
ALAB cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
ALAB balance_sheet (quarterly, 2025-06-30) — Leases: 9973000.00
ALAB cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
ALAB income_statement (quarterly, 2025-06-30) — Net Income: 51219000.00
ALAB income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 51219000.00
ALAB income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 51219000.00
ALAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 51219000.00
ALAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 51219000.00
ALAB cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 51219000.00
ALAB income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 51219000.00
ALAB income_statement (quarterly, 2025-06-30) — Net Interest Income: 10885000.00
ALAB cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -61670000.00
ALAB income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 10885000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Net PPE: 62075000.00
ALAB cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2023000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1135714000.00
ALAB income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 41166000.00
ALAB income_statement (quarterly, 2025-06-30) — Normalized Income: 51219000.00
ALAB cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 135366000.00
ALAB cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 1762000.00
ALAB income_statement (quarterly, 2025-06-30) — Operating Income: 39774000.00
ALAB income_statement (quarterly, 2025-06-30) — Operating Revenue: 191925000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 166211000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 32742000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 16044000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2874000.00
ALAB income_statement (quarterly, 2025-06-30) — Other Gand A: 20456000.00
ALAB cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2585000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 28582000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 29308000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Other Properties: 16479000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 902758000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Payables: 31573000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 53072000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 27267000.00
ALAB income_statement (quarterly, 2025-06-30) — Pretax Income: 50659000.00
ALAB cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 4737000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
ALAB cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -213861000.00
ALAB cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2023000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Raw Materials: 172000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Receivables: 24318000.00
ALAB income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 46362000.00
ALAB income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1392000.00
ALAB income_statement (quarterly, 2025-06-30) — Research And Development: 66724000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -125758000.00
ALAB cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 152191000.00
ALAB income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 18609000.00
ALAB income_statement (quarterly, 2025-06-30) — Selling General And Administration: 39065000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Share Issued: 166211000.00
ALAB cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 35474000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1135714000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1135714000.00
ALAB income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ALAB income_statement (quarterly, 2025-06-30) — Tax Provision: -560000.00
ALAB income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
ALAB balance_sheet (quarterly, 2025-06-30) — Total Assets: 1271405000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1135714000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1135714000.00
ALAB income_statement (quarterly, 2025-06-30) — Total Expenses: 152151000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 135691000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 90657000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 29308000.00
ALAB income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 39774000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Work In Process: 24104000.00
ALAB balance_sheet (quarterly, 2025-06-30) — Working Capital: 1074365000.00
ALAB income_statement (quarterly, 2025-09-30) — +Operating Expense: 120406000.00
ALAB income_statement (quarterly, 2025-09-30) — +Total Revenue: 230575000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 25811000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 42898000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -8876000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1302261000.00
ALAB cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -1789000.00
ALAB income_statement (quarterly, 2025-09-30) — Basic Average Shares: 167436000.00
ALAB income_statement (quarterly, 2025-09-30) — Basic EPS: 0.54
ALAB cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 163404000.00
ALAB cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -12293000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Capital Stock: 17000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 140407000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1134428000.00
ALAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 952000.00
ALAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -101045000.00
ALAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 78171000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -5695000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 968000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Inventory: 7471000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1382000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Payable: -5695000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -4727000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -38286000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Receivables: -18580000.00
ALAB cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -55504000.00
ALAB cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -18580000.00
ALAB cash_flow (quarterly, 2025-09-30) — Changes In Cash: -21922000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Common Stock: 17000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1271731000.00
ALAB cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
ALAB balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 45234000.00
ALAB income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 54763000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 20643000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Current Assets: 1290159000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 0.00
ALAB balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 0.00
ALAB balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 100958000.00
ALAB cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1466000.00
ALAB cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1466000.00
ALAB income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 180631000.00
ALAB income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.50
ALAB income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 91114000.00
ALAB income_statement (quarterly, 2025-09-30) — EBIT: 55406000.00
ALAB income_statement (quarterly, 2025-09-30) — EBITDA: 56872000.00
ALAB cash_flow (quarterly, 2025-09-30) — End Cash Position: 141482000.00
ALAB cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 952000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Finished Goods: 34547000.00
ALAB cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 65878000.00
ALAB cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 1880000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 4097000.00
ALAB income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 22119000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Gross PPE: 81358000.00
ALAB income_statement (quarterly, 2025-09-30) — Gross Profit: 175812000.00
ALAB income_statement (quarterly, 2025-09-30) — Interest Income: 11456000.00
ALAB income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 11456000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Inventory: 51663000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1271731000.00
ALAB cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -101045000.00
ALAB cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
ALAB balance_sheet (quarterly, 2025-09-30) — Leases: 10278000.00
ALAB cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
ALAB income_statement (quarterly, 2025-09-30) — Net Income: 91114000.00
ALAB income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 91114000.00
ALAB income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 91114000.00
ALAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 91114000.00
ALAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 91114000.00
ALAB cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 91114000.00
ALAB income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 91114000.00
ALAB income_statement (quarterly, 2025-09-30) — Net Interest Income: 11456000.00
ALAB cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -88252000.00
ALAB income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 11456000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Net PPE: 72482000.00
ALAB cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -12293000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1271731000.00
ALAB income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 56872000.00
ALAB income_statement (quarterly, 2025-09-30) — Normalized Income: 91114000.00
ALAB cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 78171000.00
ALAB cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 1880000.00
ALAB income_statement (quarterly, 2025-09-30) — Operating Income: 55406000.00
ALAB income_statement (quarterly, 2025-09-30) — Operating Revenue: 230575000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 168903000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 61170000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 14341000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 4097000.00
ALAB income_statement (quarterly, 2025-09-30) — Other Gand A: 22119000.00
ALAB cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 265000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 38541000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 28493000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Other Properties: 25846000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 994021000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Payables: 25811000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 46454000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 40163000.00
ALAB income_statement (quarterly, 2025-09-30) — Pretax Income: 66862000.00
ALAB cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 952000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
ALAB cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -259750000.00
ALAB cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -12293000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Raw Materials: 183000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Receivables: 42898000.00
ALAB income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 54763000.00
ALAB income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1466000.00
ALAB income_statement (quarterly, 2025-09-30) — Research And Development: 78928000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -34644000.00
ALAB cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 171498000.00
ALAB income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 19359000.00
ALAB income_statement (quarterly, 2025-09-30) — Selling General And Administration: 41478000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Share Issued: 168903000.00
ALAB cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 40739000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1271731000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1271731000.00
ALAB income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ALAB income_statement (quarterly, 2025-09-30) — Tax Provision: -24252000.00
ALAB income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
ALAB balance_sheet (quarterly, 2025-09-30) — Total Assets: 1401182000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1271731000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1271731000.00
ALAB income_statement (quarterly, 2025-09-30) — Total Expenses: 175169000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 129451000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 111023000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 28493000.00
ALAB income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 55406000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Work In Process: 16933000.00
ALAB balance_sheet (quarterly, 2025-09-30) — Working Capital: 1189201000.00
ALAB income_statement (annual, 2025-12-31) — +Operating Expense: 471838000.00
ALAB income_statement (quarterly, 2025-12-31) — +Operating Expense: 137517000.00
ALAB income_statement (annual, 2025-12-31) — +Total Revenue: 852525000.00
ALAB income_statement (quarterly, 2025-12-31) — +Total Revenue: 270583000.00
ALAB balance_sheet (annual, 2025-12-31) — Accounts Payable: 42362000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 42362000.00
ALAB balance_sheet (annual, 2025-12-31) — Accounts Receivable: 83202000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 83202000.00
ALAB balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -11722000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -11722000.00
ALAB balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1348969000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1348969000.00
ALAB cash_flow (annual, 2025-12-31) — Amortization Of Securities: -7932000.00
ALAB cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -1654000.00
ALAB income_statement (annual, 2025-12-31) — Basic Average Shares: 166408000.00
ALAB income_statement (quarterly, 2025-12-31) — Basic Average Shares: 169505000.00
ALAB income_statement (annual, 2025-12-31) — Basic EPS: 1.32
ALAB income_statement (quarterly, 2025-12-31) — Basic EPS: 0.27
ALAB cash_flow (annual, 2025-12-31) — Beginning Cash Position: 80044000.00
ALAB cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 141482000.00
ALAB cash_flow (annual, 2025-12-31) — Capital Expenditure: -37544000.00
ALAB cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -18689000.00
ALAB balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 4146000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 4146000.00
ALAB balance_sheet (annual, 2025-12-31) — Capital Stock: 17000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 17000.00
ALAB balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 167611000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 167611000.00
ALAB balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1188816000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1188816000.00
ALAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 9803000.00
ALAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3728000.00
ALAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -241469000.00
ALAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -72791000.00
ALAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 319306000.00
ALAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 95265000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Account Payable: 14194000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 15282000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 15770000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 16394000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Inventory: -12950000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Inventory: -5844000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -4878000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1533000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Payable: 14194000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Payable: 15282000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 29964000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 31676000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -33757000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 23003000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Receivables: -44343000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Receivables: -40254000.00
ALAB cash_flow (annual, 2025-12-31) — Change In Working Capital: -65964000.00
ALAB cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 7048000.00
ALAB cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -44343000.00
ALAB cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -40254000.00
ALAB cash_flow (annual, 2025-12-31) — Changes In Cash: 87640000.00
ALAB cash_flow (quarterly, 2025-12-31) — Changes In Cash: 26202000.00
ALAB balance_sheet (annual, 2025-12-31) — Common Stock: 17000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Common Stock: 17000.00
ALAB balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1363634000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1363634000.00
ALAB cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
ALAB cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
ALAB cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
ALAB balance_sheet (annual, 2025-12-31) — Construction In Progress: 40510000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 40510000.00
ALAB income_statement (annual, 2025-12-31) — Cost Of Revenue: 207264000.00
ALAB income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 66108000.00
ALAB balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7632000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7632000.00
ALAB balance_sheet (annual, 2025-12-31) — Current Assets: 1362030000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Current Assets: 1362030000.00
ALAB balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 4146000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 4146000.00
ALAB balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4146000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4146000.00
ALAB balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 0.00
ALAB balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 0.00
ALAB balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 0.00
ALAB balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 0.00
ALAB balance_sheet (annual, 2025-12-31) — Current Liabilities: 133042000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 133042000.00
ALAB cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 6829000.00
ALAB cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2846000.00
ALAB cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 6829000.00
ALAB cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2846000.00
ALAB income_statement (annual, 2025-12-31) — Diluted Average Shares: 179551000.00
ALAB income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 181181000.00
ALAB income_statement (annual, 2025-12-31) — Diluted EPS: 1.22
ALAB income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.25
ALAB income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 219134000.00
ALAB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 44982000.00
ALAB income_statement (annual, 2025-12-31) — EBIT: 173423000.00
ALAB income_statement (quarterly, 2025-12-31) — EBIT: 66958000.00
ALAB income_statement (annual, 2025-12-31) — EBITDA: 180252000.00
ALAB income_statement (quarterly, 2025-12-31) — EBITDA: 69804000.00
ALAB cash_flow (annual, 2025-12-31) — End Cash Position: 167684000.00
ALAB cash_flow (quarterly, 2025-12-31) — End Cash Position: 167684000.00
ALAB cash_flow (annual, 2025-12-31) — Financing Cash Flow: 9803000.00
ALAB cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 3728000.00
ALAB balance_sheet (annual, 2025-12-31) — Finished Goods: 23143000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Finished Goods: 23143000.00
ALAB cash_flow (annual, 2025-12-31) — Free Cash Flow: 281762000.00
ALAB cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 76576000.00
ALAB cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 5514000.00
ALAB cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 1498000.00
ALAB balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4310000.00
ALAB balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4310000.00
ALAB income_statement (annual, 2025-12-31) — General And Administrative Expense: 88066000.00
ALAB income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 23621000.00